SCHEMBL6449131

SCHEMBL6449131

CCCC(Cl)CC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27889472 0.85
SCHEMBL31346726 0.78
SCHEMBL11508050 0.76
SCHEMBL28520747 0.75 TSHR (0.43)
SCHEMBL1724332 0.74
SCHEMBL7890402 0.74
SCHEMBL18862614 0.74
SCHEMBL6703853 0.73
SCHEMBL11368551 0.72 TSHR (0.41)
SCHEMBL4198593 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114609309-A Pretreatment method for measuring tacrolimus ointment related substances 山东达因海洋生物制药股份有限公司 2022-06-10 CN disclosed
US-6888022-B2 Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis ATHENA NEUROSCIENCES, INC. (US) 2005-05-03 US disclosed
US-20020052322-A1 Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis ELAN PHARMACEUTICALS, INC. 2002-05-02 US disclosed
US-6342503-B1 ANTIDEPRESSANTS, EATING DISORDERS DUPONT PHARMACEUTICALS COMPANY 2002-01-29 US disclosed
US-6107301-A PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS COMPANY (US) 2000-08-22 US disclosed
US-4675341-A BRAIN INJURIES; PREVENTION OF EDEMA MERCK & CO., INC. (US) 1987-06-23 US disclosed